Dyclonine

This classification denotes an anesthetic agent with the molecular formula C18H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 078A24Q30O, chemically known as 1-propanone, 1- (4-butoxyphenyl)-3-(1-piperidinyl)-, hydrochloride but generally known as dyclonine, which bears US NIH Compound Identifier 3180. European Medicines Agency schedules Dyclonine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06432MIG. The term DYCLONINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules dyclonine in its Anatomical Therapeutic Chemical (ATC) Classification. DYCLONINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dyclonine under HS 29333999 and SITC 51574. As of Q4 2014, DYCLONINE remains the US FDA Preferred Term for this commodity. Dyclonine bears US NLM identifiers UMLS ID C0058831 and NCI Concept Code C29015. SMILES: O=C(CCN1CCCCC1)C1CCC(OCCCC)CC1.